AC 162352
Alternative Names: peptide YY3-36Latest Information Update: 05 Nov 2023
At a glance
- Originator Curis
- Developer Amylin Pharmaceuticals
- Class Obesity therapies; Peptide hormones
- Mechanism of Action Peptide hormone stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Obesity